Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Gsk Plc ADR (NY: GSK ) 38.21 -0.17 (-0.44%) Official Closing Price Updated: 7:00 PM EDT, Jul 2, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 3,354,100 Open 38.11 Bid (Size) 37.72 (1) Ask (Size) 38.48 (2) Prev. Close 38.38 Today's Range 37.80 - 38.32 52wk Range 33.67 - 45.92 Shares Outstanding 5,385,189,617 Dividend Yield 3.78% Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Heartburn Drug Zantac Litigation: GSK And Other Pharma Giants Face Trial Over Cancer Claims Today 8:39 EDT A Delaware judge dismissed GSK and other drugmakers' appeal, allowing over 70,000 lawsuits alleging Zantac causes cancer to proceed, with the companies needing Delaware Supreme Court approval to... Via Benzinga Topics Lawsuit Exposures Financial Legal CDC Advisor Panel Recommends RSV Shots In US For People Above 75 Years, Analyst Says Decision Negative For GSK June 27, 2024 The CDC's ACIP recommends RSV vaccines for adults 75+, and for those 60-74 with chronic conditions. GSK's Arexvy is approved for adults 50-59 at risk. A decision on adults 50-59 is pending further... Via Benzinga Performance YTD +1.87% +1.87% 1 Month -6.53% -6.53% 3 Month -9.92% -9.92% 6 Month +1.87% +1.87% 1 Year +8.27% +8.27% More News Read More Why Is Moderna Stock Trading Lower On Wednesday? June 26, 2024 Via Benzinga Exposures COVID-19 Moderna Crumbles After RSV Vaccine Effectiveness Pales Vs. Pfizer, GSK Shots June 26, 2024 Via Investor's Business Daily Sanofi Looks To Sell $20B Icy Hot Division: Likely Bidders Include Advent, PAI Partners, Blackstone, CVC June 26, 2024 Via Benzinga UK Chooses Pfizer Over GSK for Multi-Million Dose RSV Vaccine Contract June 24, 2024 Via Benzinga Industry Groups Back GSK's Effort To Halt 70,000 Lawsuits Associated With Heartburn Drug Zantac Caused Cancer June 20, 2024 Via Benzinga Topics Lawsuit Exposures Financial Legal Pancreatic Cancer Market Is Projecting to Expand As NCI-Funded Research Expects to Empower Market Growth June 20, 2024 Via FinancialNewsMedia Topics Death Exposures Death Pancreatic Cancer Market Is Projecting to Expand As NCI-Funded Research Expects to Empower Market Growth June 20, 2024 From FN Media Group LLC Via GlobeNewswire Analyst Projects Strong Growth for GSK-Innoviva Partnered Respiratory Drugs June 18, 2024 Via Benzinga 7 A-Rated Biotech Stocks Worth Betting on in June June 14, 2024 Via InvestorPlace 3 Penny Stocks That Can Deliver Over 5,000% Upside by 2025: June Edition June 11, 2024 Via InvestorPlace Moderna Says Combination Flu And Covid Vaccine Beat Out Rivals From Sanofi, GSK June 10, 2024 Via Investor's Business Daily Exposures COVID-19 US FDA Approves Expanded Age Indication for GSK’s AREXVY, the First Respiratory Syncytial Virus (RSV) Vaccine for Adults Aged 50-59 at Increased Risk June 07, 2024 From GSK plc Via Business Wire The 3 Most Undervalued Pharma Stocks to Buy in June 2024 June 06, 2024 Via InvestorPlace Topics Economy Exposures Economy Large Cap BIopharmaceuticals Overview June 03, 2024 Via Talk Markets Topics Stocks Exposures US Equities GSK Stock Falls as 70,000 Zantac Lawsuits Move Forward. What to Know. June 03, 2024 Via InvestorPlace Topics Lawsuit Exposures Financial Legal GSK's Blenrep Combo Therapy Cuts Risk Of Disease Progression Or Death By Around 50% In Pretreated Multiple Myeloma June 03, 2024 Via Benzinga Zantac Heart Burn Continues For GSK As US Court Ruling Allows Thousands Of Zantac Lawsuits To Move Forward June 03, 2024 Via Benzinga Topics Lawsuit Exposures Financial Legal Why Science Applications International Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Monday's Mid-Day Session June 03, 2024 Via Benzinga GSK, Boston Beer And Other Big Stocks Moving Lower In Monday's Pre-Market Session June 03, 2024 Via Benzinga Jemperli (dostarlimab-gxly) trial continues to show unprecedented results with no evidence of disease in 100% of patients with locally advanced mismatch repair deficient (dMMR) rectal cancer June 03, 2024 From GSK plc Via Business Wire Is Moderna Stock a Buy Now That It's a 2-Product Company? June 03, 2024 Via The Motley Fool Why GameStop Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket June 03, 2024 Via Benzinga Belantamab Mafodotin combination reduced the risk of disease progression or death by nearly 50% versus standard of care combination in relapsed/refractory multiple myeloma June 02, 2024 From GSK plc Via Business Wire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.